Dornase alfa biosimilar (Universisty of Illinois)

阿法链道酶生物类似药(伊利诺伊大学芝加哥分校)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDornase alfa biosimilar (Universisty of Illinois)
Drug Alias Name阿法链道酶生物仿制药(伊利诺伊大学芝加哥分校)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionDeoxyribonuclease 1 repalcementsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsGraft vs Host DiseaseXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGraft vs Host DiseaseXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeR05CB13
Related LinksN/A